Indivior loses U.S. district court battle, copycat launches imminent
Reuters India -

Generic competitors to British drugmaker Indivior Plc's blockbuster opioid addiction treatment are on course to launch sales next week after the firm's attempt to stay a U.S. District court judgement was rejected.

Read this story at


Related Articles